146 related articles for article (PubMed ID: 7597445)
21. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
22. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
23. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis viruses as aetiological agents of hepatocellular carcinoma.
Alberti A; Pontisso P
Ital J Gastroenterol; 1991; 23(7):452-6. PubMed ID: 1660332
[TBL] [Abstract][Full Text] [Related]
25. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
[TBL] [Abstract][Full Text] [Related]
26. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
27. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
28. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
[TBL] [Abstract][Full Text] [Related]
29. Etiological factor of hepatocellular carcinoma in Italy.
Stroffolini T
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):1-5. PubMed ID: 15756142
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
Bréchot C; Minami M; De Mitri S; Paterlini P
Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
[TBL] [Abstract][Full Text] [Related]
31. [Breakthrough in human hepatocellular carcinogenesis--from hepatitis B virus to hepatitis C virus].
Nishioka K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):327-36. PubMed ID: 1848417
[TBL] [Abstract][Full Text] [Related]
32. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.
Takano S; Yokosuka O; Imazeki F; Tagawa M; Omata M
Hepatology; 1995 Mar; 21(3):650-5. PubMed ID: 7875662
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
34. Does non-A, non-B hepatitis cause hepatocellular carcinoma?
Purcell RH
Cancer Detect Prev; 1989; 14(2):203-7. PubMed ID: 2559795
[TBL] [Abstract][Full Text] [Related]
35. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
36. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
37. [Clinical picture and evolution of hepatitis C].
Marcellin P; Erlinger S
Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
[TBL] [Abstract][Full Text] [Related]
38. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
39. Relationship between hepatocellular carcinoma and cirrhosis.
Kew MC; Popper H
Semin Liver Dis; 1984 May; 4(2):136-46. PubMed ID: 6087459
[TBL] [Abstract][Full Text] [Related]
40. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
